Elanco Animal Health Inc - COMMON STOCK (ELAN)

Historical Holders from Q1 2016 to Q4 2025

Type / Class: Equity / COMMON STOCK
Symbol: ELAN on NYSE
Shares outstanding: 492,937,031
Price per share: $22.63
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares: 570,763,093
Total reported value: $11,494,667,666
% of total 13F portfolios: 0.01%
Share change: +32,508,916
Value change: +$680,251,195
Number of holders: 401
Price from insider filings: $22.63

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of Elanco Animal Health Inc - COMMON STOCK (ELAN) based on Schedule 13D/G filings

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
FMR LLC	13%	+31%	$626,124,786	+$148,052,944	64,883,398	+31%	FMR LLC	30 Jun 2025
BlackRock, Inc.	8.9%	+112%	$886,598,367	+$443,042,097	44,021,766	+100%	BlackRock, Inc.	30 Sep 2025
T. Rowe Price Investment Management, Inc.	6.4%		$635,376,116		31,547,970		T. Rowe Price Investment Management, Inc.	30 Sep 2025

As of 30 Sep 2025, Elanco Animal Health Inc - COMMON STOCK (ELAN) has 401 institutional shareholders filing 13F forms. They hold 570,763,093 shares. .

Top 25 institutional shareholders own 98% of the company.

Filer	Ownership	Nb Shares	Share Change %	Portfolio %	Holdings Value
Dodge & Cox	17%	82,759,837	-0.16%	0.9%	$1,666,783,117
FMR LLC	13%	65,357,380	+0.73%	0.07%	$1,316,297,631
PRIMECAP MANAGEMENT CO/CA/	10%	49,958,156	-3.5%	0.77%	$1,006,157,262
VANGUARD GROUP INC	9.9%	48,586,708	+1.6%	0.01%	$978,536,298
BlackRock, Inc.	9.4%	46,178,502	+100%	0.02%	$930,035,025
T. Rowe Price Investment Management, Inc.	6.4%	31,510,014	+61%	0.39%	$634,612,000
DIMENSIONAL FUND ADVISORS LP	5%	24,708,676	+8.6%	0.11%	$497,609,839
UBS Group AG	3.3%	16,468,148	+57%	0.06%	$331,668,501
STATE STREET CORP	3.1%	15,245,783	+67%	0.01%	$307,050,070
Black Creek Investment Management Inc.	2.5%	12,482,461	-35%	12%	$251,396,765
MORGAN STANLEY	2.1%	10,265,905	+2.9%	0.01%	$206,755,378
GEODE CAPITAL MANAGEMENT, LLC	1.8%	8,785,435	+8.9%	0.01%	$176,973,060
MANUFACTURERS LIFE INSURANCE COMPANY, THE	1.5%	7,583,575	+26%	0.13%	$152,733,201
Nuveen, LLC	1.4%	7,083,854	-14%	0.04%	$142,668,820
SHAPIRO CAPITAL MANAGEMENT LLC	1.3%	6,396,549	-31%	5.6%	$128,826,497
BRANDES INVESTMENT PARTNERS, LP	1.2%	5,939,517	-27%	0.96%	$119,621,872
Clearbridge Investments, LLC	1.2%	5,897,598	+9.3%	0.09%	$118,777,626
MILLENNIUM MANAGEMENT LLC	1.1%	5,612,831	+46%	0.09%	$113,042,416
Bank of New York Mellon Corp	1%	5,131,116	+190%	0.02%	$103,340,670
BARROW HANLEY MEWHINNEY & STRAUSS LLC	1%	5,036,147	-34%	0.32%	$101,428,001
FULLER & THALER ASSET MANAGEMENT, INC.	1%	4,971,877	-2.6%	0.34%	$100,133,610
CITADEL ADVISORS LLC	0.98%	4,843,380	-65%	0.08%	$97,545,673
NORTHERN TRUST CORP	0.87%	4,291,618	+48%	0.01%	$86,433,186
JENNISON ASSOCIATES LLC	0.81%	3,974,347	+23%	0.05%	$80,043,348
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	0.8%	3,919,139	-8.4%	0.01%	$78,931,459

Institutional Holders of Elanco Animal Health Inc - COMMON STOCK (ELAN) across Reporting Periods

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price	Investors
2025 Q4	202,389	$4,612,924	-$272,902			$22.63	12
2025 Q3	570,763,093	$11,494,667,666	+$680,251,195	$21,762,648	$15,679,043	$20.14	401
2025 Q2	538,352,937	$7,687,668,693	+$655,647,844	$20,244,633	$12,392,528	$14.28	362
2025 Q1	493,974,636	$5,186,990,807	+$2,004,670	$7,043,028	$7,532,565	$10.50	358
2024 Q4	489,312,361	$5,925,539,482	+$69,636,315	$13,607,690	$13,981,675	$12.11	385
2024 Q3	478,262,809	$7,023,316,156	-$80,586,947	$11,046,851	$67,858,714	$14.69	385
2024 Q2	482,196,989	$6,957,807,162	+$62,799,838	$18,011,526	$43,923,477	$14.43	398
2024 Q1	476,152,105	$7,751,469,331	-$13,044,644	$14,912,080	$42,350,392	$16.28	372
2023 Q4	2,494,675	$37,170,657	-$338,178			$14.90	3
2023 Q3	477,195,830	$5,362,168,812	+$117,558,138	$9,988,864	$13,102,468	$11.24	342
2023 Q2	467,231,375	$4,698,802,420	-$72,072,911	$13,094,660	$22,092,276	$10.06	339
2023 Q1	476,119,377	$4,463,953,559	-$89,993,788	$12,551,340	$21,413,840	$9.40	376
2022 Q4	475,931,946	$5,837,895,160	+$243,826,626	$16,030,818	$36,670,570	$12.22	389
2022 Q3	460,269,551	$5,721,188,950	-$116,009,448	$14,931,000	$87,595,000	$12.41	388
2022 Q2	450,688,207	$8,847,057,486	-$83,710,914	$14,360,000	$12,292,000	$19.63	410
2022 Q1	471,868,736	$12,323,305,251	-$35,456,333	$34,154,000	$22,290,000	$26.09	449
2021 Q4	471,923,345	$13,373,902,634	+$167,342,495	$64,782,000	$31,495,000	$28.38	454
2021 Q3	442,099,888	$14,100,116,303	-$90,156,737	$28,395,000	$52,288,000	$31.89	435
2021 Q2	437,322,447	$15,176,315,086	+$247,484,090	$59,504,000	$56,835,304	$34.69	460
2021 Q1	432,569,751	$12,738,222,068	+$163,437,441	$75,609,090	$41,552,875	$29.45	427
2020 Q4	426,499,690	$13,074,629,728	+$1,144,897,184	$85,036,654	$38,677,250	$30.67	417
2020 Q3	409,336,032	$11,420,444,049	+$507,354,498	$60,861,000	$18,583,000	$27.93	341
2020 Q2	395,078,422	$8,481,769,677	-$185,690,163	$17,364,000	$37,905,000	$21.45	349
2020 Q1	400,288,752	$8,961,927,270	+$568,188,925	$23,942,000	$31,386,000	$22.39	343
2019 Q4	368,016,604	$10,837,193,241	-$50,824,947	$30,447,000	$30,917,000	$29.45	385
2019 Q3	370,125,395	$9,840,756,595	-$152,293,334	$44,177,000	$23,183,000	$26.59	353
2019 Q2	374,912,836	$12,674,900,505	+$596,476,282	$20,321,000	$17,468,000	$33.80	361
2019 Q1	373,748,762	$11,986,564,928	+$9,238,396,533	$52,424,000	$33,956,000	$32.07	339
2018 Q4	84,694,470	$2,670,369,996	+$415,525,469	$1,220,000	$136,000	$31.53	160
2018 Q3	71,072,507	$2,458,486,844	+$2,458,211,273			$34.89	151
2016 Q1	186	$6,000	$0			$32.26	1